Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219082 · ClinicalTrials.gov registry record · NA
Behavioral Safety and Fentanyl Education: BSAFE
A NA study, sponsored by San Francisco Department of Public Health.
- Not yet
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT07219082: Clinical Trial NA study, sponsored by San Francisco Department of Public Health.
NCT07219082 is a NA study that has not yet begun recruiting, run by San Francisco Department of Public Health. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219082, a NA study, has not yet begun recruiting, sponsored by San Francisco Department of Public Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of BSAFE vs attention-control.
Primary Outcome
Incidence of overdose will be measured by a composite measure of non-fatal and fatal overdose count collected by blinded assessors from Timeline Follow-Back (TLFB) every 4 months and vital record linkage for overdose fatalities.
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL BSAFE Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2030-01-15 |
| Phase | NA |
What is known before NCT07219082 opens enrollment
NCT07219082 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT07219082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07219082 about?
NCT07219082 is a clinical study titled "Behavioral Safety and Fentanyl Education: BSAFE". BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. Thi...
What is the current status of trial NCT07219082?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-06-15. Estimated completion is 2030-01-15.
What interventions are being tested in trial NCT07219082?
The interventions under investigation include: Attention control (BEHAVIORAL), BSAFE Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07219082?
This trial is sponsored by San Francisco Department of Public Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07219082's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI